Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee
Conditions
Interventions
ACP-044 Dose A
ACP-044 Dose B
+1 more
Locations
34
United States
Clinical Research Investment, LLC
Birmingham, Alabama, United States
AOC-Research
Birmingham, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
BioSolutions Clinical Research Center
La Mesa, California, United States
Velocity Clinical Research, North Hollywood
North Hollywood, California, United States
Artemis Headlands, LLC
San Diego, California, United States
Start Date
July 20, 2021
Primary Completion Date
October 6, 2022
Completion Date
November 16, 2022
Last Updated
January 9, 2025
Lead Sponsor
ACADIA Pharmaceuticals Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions